The agreement, which begins in January, gives Sanova exclusive distribution rights to sell Tissuemed’s TissuePatch Product Family. TissuePatch is a self-adhesive film, which adheres to the body’s internal tissues to prevent the leakage of blood, air and other fluids, including cerebrospinal fluid encountered in surgery.
Tissuemed’s CEO David Mandley, said: “I’m delighted to be working with our colleagues at Sanova to promote TissuePatch and TissuePatchDural in Austria. Sanova’s Medical Systems Division distribute a range of products that complement Tissuemed’s sealant technology and their highly experienced sales team have a good reach into the operating theatre”.
Harald Deutsch, Sanova´s Head of Medical Systems Division commented. “We are glad to add TissuePatch and TissuePatchDural to our product portfolio. These innovative solutions will strengthen our leading position in the Austrian healthcare market and will support our mission which is aiming to improve the quality of life of our fellow human beings.”